Blocking the attachment of germs to human cells
AssigneeLaevosan-Gesellschaft GmbH
InventorsJosef Peter Guggenbichler, Peter Meissner, Johann Jurenitsch, Andreas De Bettignies-Dutz
Life of this patent
Estimating the term…
Abstract
The invention concerns a pharmaceutical preparation which contains one or several galacturonides as the active substance with a degree of polymerization of .gtoreq.2 and a degree of esterification of <20% optionally together with common pharmaceutical carriers, diluents, auxiliary substances and fillers as well as the use of this preparation to block the attachment of germs to mammalian cells.
Claims13
A method of blocking germs from attachment to epithelial cells, or displacing germs bound to epithelial cells, in a mammalian patient, the method comprising administering to the patient an effective amount of at least one galacturonide having a degree of polymerization of .gtoreq.2 and a degree of esterification of <20%.
Process for blocking the attachment of germs to mammalian epithelial cells, wherein the epithelial cells are contacted by at least one galacturonide having a degree of polymerization of .gtoreq.2 and a degree of esterification of <20%.
Dependencies are inferred from the claim text.